<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00113867</url>
  </required_header>
  <id_info>
    <org_study_id>AG0022</org_study_id>
    <nct_id>NCT00113867</nct_id>
  </id_info>
  <brief_title>Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal Women</brief_title>
  <official_title>Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute on Aging (NIA)</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effects of marked alterations in ovarian steroid&#xD;
      hormones on cognitive functions in women. Sex hormones and stress hormones of women awaiting&#xD;
      or undergoing in-vitro fertilization (IVF) will be compared with levels of women adopting&#xD;
      children and women on oral contraceptives.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Much of our understanding of the effects of ovarian steroid hormones on cognitive functioning&#xD;
      comes from studies of changes in cognitive function associated with hormone replacement&#xD;
      therapy (HRT) in post-menopausal women and changes in menstrual cycle phase in premenopausal&#xD;
      women. If fluctuations in ovarian sex steroid hormone levels across the normal physiological&#xD;
      range affect cognitive functions in women, then marked alterations in hormone levels should&#xD;
      have a notable effect on cognitive function.&#xD;
&#xD;
      Hormonal in-vitro fertilization (IVF) treatments for female infertility result in dramatic&#xD;
      fluctuations in estrogen levels. Women awaiting infertility treatment report negative&#xD;
      emotions, depressed mood, declines in memory and concentration, and higher levels of reported&#xD;
      stress compared to women who have never experienced infertility.&#xD;
&#xD;
      Four groups of twenty women each will be recruited for this observational study:&#xD;
&#xD;
        -  Group 1 - IVF treatment with GnRH-a alone&#xD;
&#xD;
        -  Group 2 - IVF treatment with GnRH-a plus sex steroid stimulating hormones&#xD;
&#xD;
        -  Group 3 - ADPT control (women in the process of adopting children)&#xD;
&#xD;
        -  Group 4 - OC (oral contraceptives) control&#xD;
&#xD;
      All groups will receive a cognitive/affect assessment twice, with a 3-week interval between&#xD;
      assessments. Blood and salivary samples will be taken on the two test days to measure ovarian&#xD;
      sex steroid hormone levels and stress hormone levels. Salivary samples will also be taken on&#xD;
      a third day in between the two test days. Heart Period Variability (HPV), a measure of&#xD;
      cardiac functioning, will be measured using electrocardiogram (ECG).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <primary_completion_date type="Actual">November 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment>80</enrollment>
  <condition>Infertility</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women 25 years and older, who are still ovulating&#xD;
&#xD;
          -  Residing in Maryland or the Washington DC metropolitan area&#xD;
&#xD;
          -  Healthy women in one of the following groups:&#xD;
&#xD;
          -  1) beginning or currently undergoing IVF infertility treatments with GnRH-a alone,&#xD;
&#xD;
          -  2) beginning or currently undergoing IVF infertility treatments with GnrH-a plus sex&#xD;
             steroid stimulating hormones,&#xD;
&#xD;
          -  3) going through the adoption process, or&#xD;
&#xD;
          -  4) taking monophasic oral contraceptives for at least six months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  English not the primary language&#xD;
&#xD;
          -  Women who are peri- or post-menopausal&#xD;
&#xD;
          -  Women who are currently taking anti-depressants or have a history of head injury or&#xD;
             neurological/psychiatric condition&#xD;
&#xD;
          -  Groups 1 &amp; 2 (IVF) - women who are undergoing Inter-uterine insemination as an&#xD;
             infertility treatment&#xD;
&#xD;
          -  Group 3 (ADPT) - women who underwent hormonal infertility treatments within the&#xD;
             previous 6 months&#xD;
&#xD;
          -  Group 4 (OC) - women on progesterone only (mini-pill) oral contraceptives&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melissa H. Kitner-Triolo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Psychologist, Laboratory of Personality &amp; Cognition, Cognition Section, Intramural Reserach Program, National Institute on Aging, National Institutes of Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institute on Aging (NIA), Harbor Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sherwin BB, Tulandi T. &quot;Add-back&quot; estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab. 1996 Jul;81(7):2545-9.</citation>
    <PMID>8675575</PMID>
  </reference>
  <reference>
    <citation>Harlow CR, Fahy UM, Talbot WM, Wardle PG, Hull MG. Stress and stress-related hormones during in-vitro fertilization treatment. Hum Reprod. 1996 Feb;11(2):274-9.</citation>
    <PMID>8671208</PMID>
  </reference>
  <reference>
    <citation>Oddens BJ, den Tonkelaar I, Nieuwenhuyse H. Psychosocial experiences in women facing fertility problems--a comparative survey. Hum Reprod. 1999 Jan;14(1):255-61.</citation>
    <PMID>10374131</PMID>
  </reference>
  <verification_date>November 2006</verification_date>
  <study_first_submitted>June 10, 2005</study_first_submitted>
  <study_first_submitted_qc>June 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2005</study_first_posted>
  <last_update_submitted>December 9, 2009</last_update_submitted>
  <last_update_submitted_qc>December 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2009</last_update_posted>
  <keyword>IVF</keyword>
  <keyword>in vitro fertilization</keyword>
  <keyword>hormones</keyword>
  <keyword>stress</keyword>
  <keyword>memory</keyword>
  <keyword>Cognitive Function</keyword>
  <keyword>adoption</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

